Comparative outcome and prognostic factor analysis among MDS/AML patients with TP53 mutations, snps, and wild type.

Hum Genomics · 2025 · PMC12395695 · PMID 40877983

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

Our findings suggest that TP53 SNP carriers may have a comparable or even better prognosis than TP53 wild-type patients, despite some recent studies indicating a possible trend toward worse OS probability in patients with TP53 P72R [ 21 , 22 ].

also in 808 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.